A Study to Assess YH003 in Combination with Toripalimab(anti-PD-1 MAb) Injection in Patients with Cancers
Clinical trial NCT05031494 · COMPLETED
Trial details
- NCT number
- NCT05031494
- Sponsor
- Eucure (Beijing) Biopharma Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-08
- Primary completion
- 2023-08-16
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.